Open Access<p>Screening and Identifying Cisplatin-Related Gene Mutations in Lung Squamous Cell Carcinoma</p>
Author(s) -
Xiaohua Li,
Yuntao Wang,
Sheng Hu,
Yifeng Bai
Publication year - 2020
Publication title -
pharmacogenomics and personalized medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.845
H-Index - 28
ISSN - 1178-7066
DOI - 10.2147/pgpm.s264545
Subject(s) - cisplatin , medicine , oncology , cohort , chemotherapy , cancer research
Platinum-based chemotherapy is the cornerstone of treatment for patients with LUSC, but cisplatin resistance greatly restricts its clinical application. Therefore, it is particularly important to screen the predominant LUSC population using biomarkers.